|
|
||||||||
Clinical Investigations |
1 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel
2 Organ Transplantation Unit, Department of Surgery "B," Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel
We used 99mTc-dimercaptosuccinic acid (DMSA) quantitative SPECT (QDMSA) to assess the function of kidneys before harvesting and after transplantation as well as the function of remaining donor kidneys. Methods: Nineteen kidney donors underwent a baseline QDMSA study before nephrectomy. The allografts of these kidneys were studied in recipients at 1 wk, 12 mo, and 615 mo after transplantation. The kidneys remaining in 16 donors were studied at 12 mo and 615 mo after harvesting. The parameters obtained in each SPECT study included functional volume, concentration of 99mTc-DMSA per cubic centimeter of renal tissue, and total kidney uptake. Clinical evaluation and determination of serum creatinine levels took place at the same time as SPECT. Results: On the basis of the clinical evaluation, 14 grafts had normal function and 5 were impaired. The mean ± SD of kidney uptake values expressed as percentage of baseline values were 131% ± 30% in normal grafts versus 57% ± 5% in impaired grafts at 1 wk (P < 0.01), 173% ± 57% versus 65% ± 10% at 12 mo (P < 0.001), and 190% ± 50% versus 69% ± 14% at 615 mo after transplantation (P < 0.01). Uptake values in the donors remaining kidneys were 159% ± 27% of baseline values at 12 mo and 164% ± 30% at 615 mo after nephrectomy. Allografts and remaining kidneys showed a similar increase in total kidney uptake as a result of an increase in both functional volume and concentration. Conclusion: QDMSA may be a noninvasive assessment tool in kidney transplantation from living donors.
Key Words: transplantation SPECT 99mTc-dimercaptosuccinic acid
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |